Exam 4 Flashcards

1
Q

Lecture 1 Bovine Respiratory Introduction and PE

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Immunomodulation in Bovine Respiratory Disease

A

-Cortisol Increases due to stress
-BVD, IBR, PI-3
-Pasteurella hemolytic, P. multicocida, Haemophilus somnus.
-Neutrophils defective in function
-Cellular and molecular interference with neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe BRD associated risk factors and their mechanisms

A

BRD External Risk Factors

  1. Transportation
  2. Commingling
  3. Antibiotics and vaccination
  4. Disease and pathogen exposure
  5. Genetics and epigenetic
  6. Maternal microbiome
  7. Environment and housing
  8. Age
  9. Weaning
  10. Dietary changes

Immune system insults

-Stress
-Dehydration: Decreased aqueous layer = all cilia trapped in mucus layer = decreased clearance = increased airway irritation and organisms number
-Co-infections
-Inadequate nutrition

BRD Internal Risk Factors

  1. Anatomy: compared to horses, lung capacity is 1/2.
    -Tortuous architecture
    -Lobular structure: minimal collateral air circulation, limited ability to compensate for damaged areas
  2. Innate Immunity
    -Mucociliary apparatus
    -Cellular component
    -Cytokine component
    -Immune modulation
    Prevents/inhibits pathogens from colonizing in airway locations where they can cause disease
    -Pathogenic bacteria can be normal inhabitants of upper airways. Primary or secondary

BRD Behavioral Risk Factors

  1. Prey animals: tend to disguise how they feel to avoid appearing vulnerable to predators
  2. Humans considered predators (not always) hinders identification of sick animals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe how to obtain a history and observe a farm for BRD risk factors

A

-Number of animals affected
-Age of animals affected: young more vulnerable
-New additions to the herd: naive herd, introduction of disease
-Vaccination history: what vaccines, how often, how efficacy
-Therapies given
-Client’s response accuracy: don’t know, won’t tell, forgot, etc.

On Farm Observations

-Drought, other environmental condition
-Hungry cattle
-Head and neck extension strongly suggests respiratory system
-Associated with feeding peanut vine hay

  1. Climate: cattle like cooler temperatures. Shield from hard snow, rain, wind
  2. BCS - Energy of herd
  3. Nutrition: pasture condition, concentrate, etc.
  4. Sanitation: ammonia, mud in dry lots
  5. Housing: pasture, dry lot, crowding, ventilation
  6. Storage and use of vaccines
  7. General management level
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe how to perform a PE related to BRD and interpret findings

A
  1. BRD at a distance: “Natural behavior” vs. abnormal behavior
    -Separation from others
    -Minimal feed intake
    -Drinking reduced, rumen fill
    -Discharges, nasal ocular
    Head and neck extended
    Lethargic
    -Reduced activity, shuffle feet, droopy ears, electronic monitoring (detect 2-4 days earlier)
    -Chronic: wasting away
  2. Body symmetry: bloat present?
    -Death from suffocation due to pressure on thoracic cavity from rumen
    -Always relieve bloat first
  3. Breathing pattern: dyspnea present?
    -Normal adult: 15-35 bpm, Neonatal: 20-50 bpm

Dyspnea types
-Inspiratory effort = cranial to thoracic inlet
-Expiratory = intrathoracic disease
-Breathing through mouth or nose

  1. Rectal temp: “touching” contact
    -Normal: 99-102.5F
    -Viral 105-107F
    -Heat stress also increases temp
  2. Auscultation: lung fileds, upper airway (trachea)
    -Behind elbow
    -Mid-chest
    -Dorsal lung field ~6-9th intercostal space
    Bacterial pneumonia is cranial ventral, Lungworms and mycoplasma more dorsal
    -Wheezes, whistles, crackles, increased sounds compared to normal
    -Abnormal or absence of sound (consolidation) maybe significant
    -Use rectal sleeve to induce deep breath

Heart Sounds

-Maybe muffled, normal, louder (referred through consolidated tissue)
-May obscure soft or subtle lung sounds

Percussion

-Simultaneous over rib and auscultation
-Identifies areas of consolidation

  1. Palpation of larynx and trachea
    -Visualization: endoscope
    -External palpation may elicit cough or pain: suggest tracheal irritation = respiratory problem
  2. Head/neck symmetry, swellings
    -Face, head, neck, eyes, airflow via nostrils, sinuses (swelling, percussion)
  3. MMs, mouth, oral cavity
    -Discharge, forth, foaming
    -Mucosa color: pale (anemia), reddening (inflammation)
    -Vesicles, ulcers, erosions
    -Blunting of papilla
    -Capillary refill time
    -Odor of breath, maybe necrotic suggesting aspiration pneumonia
  4. Nasal and ocular discharge
    -Serous: early on
    -Mucopurulent: later
    -Unilateral, bilateral: localized vs. systemic/generalized disease
    -Amount: increased, decreased, plugged nasolacrimal duct
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe methods for sample collection and laboratory testing

A

Diagnostic Aids

-CBC not necessary if you hear typical pneumonic lungs sounds
-Parasitology: Baerman technique (lungworms)
-Thoracic radiographs (challenging in adults)
-Ultrasound
-Endoscopy
-Transtracheal washing
-Nasal or laryngeal swabs
-Blood analysis

Necropsy

-Appropriate samples for bacteriology, virology, histopathology
+/- Euthanasia of acute case for diagnosis

Dx

-Nasopharyngeal Swab: contamination, lower airway representation limited
-Transtracheal Wast or Aspirate: invasive
-Nonendoscopic Bronchoalveolar Lavage: contamination risk BAL
-Endoscopic Bronchoalveolar Lavage: Cost, equipment needs
Viruses vs. Bacteria, LOCATION!

-Work with diagnostic lab to develop protocol
-Recognize limitations and advantages of each Dx method/sampling
-Nasal swabs for viruses maybe helpful, PCR antemortem.
-Tracheal wash for viruses and bacteria identification

Summary

-Can’t culture from fixed tissues
-Hard to do histopath on frozen tissues
-Microbial culture for bacteria
-PCR mainly viruses
-Serology - antibodies
-Direct MALDI-TOF for bacteria
-Nonsequencing mainly viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe how to diagnose, treat, and manage diseases and conditions of the nasal cavity and sinuses

A

Nasal Cavity and Sinuses

  1. Nasal Granuloma
    Mycotic Bovine Nasal Granuloma
    -Sporadic, rare
    -Fungi, bacteria involved
    -Unilateral or bilateral

C/S
-Upper respiratory noise
-Mucopurulent discharge
-/+ epistaxis

Dx

-Endoscopy
-Biopsy of lesion and culture

Tx

-Difficult
-Surgical resection if possible
-Long-term iodine sodium therapy??
-Consider lavage
-Slaughter, auction region specific

  1. Allergic Rhinitis

-Usually adults, families
-Plant pollen or fungal spore causative agents
-May be seasonal

C/S

-Bilateral serous nasal discharge
-Stertorous breathing (reverse snoring like sound)
-Intense pruritic (rubbing of nose)
-May lead to multiple nasal granulomas

Tx

-Antihistamines
-Corticosteroids parenteral or topical
-Prolonged tx
-Live with or cull

  1. Sinusitis (post dehorning)

-Frontal sinus secondary to dehorning
-Maxillary sinus: extension from root infection
-Typically unilateral

C/S

-Anorexia
-Lethargy
-Nasal discharge (unilateral)
-Facial swelling/exopththalmos

Dx

-Percussion
-Radiographs
Best time to dehorn <4-5 mts of age

Tx

-Drain
-Flush with antiseptic solution
-Parenteral antibiotics
-NSAID for pain
-Sinusotomy via trephine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe how to diagnose, treat and manage diseases and conditions of the larynx, pharynx, and trachea

A

Larynx, Pharynx, and Trachea

  1. Pharyngeal trauma and abscess

-Secondary to iatrogenic injury Balling gun, stomach tube, esophageal feeder or rough, stemmy feeds.
-Prelube equipment, water or mineral can be used

C/S

-Respiratory dyspnea on inspiration
-Digestive trouble swallowing
-Palpate swellings, aspirate??

Dx

-Endoscopy
-Radiographs

Tx

-Discrete abscesses can be drained preferably into pharynx (aspirate first)
-Cellulitis must be treated medically
-Antibiotics: broad spectrum or based on culture
-Consider slaughter

Prognosis
-Good for mild, discrete lesions
-Guarded or diffuse lesions

  1. Necrotic laryngitis (calf diphtheria)

-Fusobacterium necrophorum
-Young, 1-18 mts usually 1-4 mts of age

C/S

-URT infection
-Increased coughing leads to laryngeal trauma and erosion of mucosa over vocal processes and arytenoids (ulcers)
-Opportunistic infection of eroded mucosa by F. necrophorum
-Acute onset
-Anorexia
-Depression
-Fever
-Severe inspiratory dyspnea
-Foul odor breath
-Death possible
Recovered cases have roaring noise from misshapen larynx

Dx

-C/S, history, visual lesions, oral exam

Tx

-Antibiotics injection
Oxytet, Penicillin
-Anti-inflammatories: Dexamethosone
-/+ Tracheostomy: 1-2 weeks, when severe dyspnea, cyanosis.

Prognosis
-Fair for survival, some may need surgery

  1. Tracheal edema syndrome “Honker Cattle”

-Heavy feedlot cattle 2/3 of feeding period
-Unknown etiology

C/S

-Edematous thickening of the dorsal membranes of the trachea
-Inspiratory dyspnea
-Cyanosis
-Honking
-Death by asphyxiation <24 hours (tracheostomy needed)

Tx

-Antibiotics
-Corticosteroids
-Tracheostomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stertor vs. Stridor breathing

A

Stertor is a sound similar to snoring, while stridor, which is commonly associated with laryngeal disease, is a more high pitched sound. During upper airway obstruction, normal inspiration causes negative pressure inside the upper airways, resulting in collapse of weaker or less supported tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lecture 2 Objectives

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

For each of the four major viruses, be able to describe in general each of the specific topics below

A

Virus characteristics
Name
Physical durability
Genetic features
Epidemiology: transmission, distribution, importance
Pathogenesis
C/S
Dx
Prevention and Control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Primary Viruses

A
  1. Infectious Bovine Rhinotraceitis (IBR) (BHV-1)
  2. Bovine Respiratory Syncytial Virus (BRSV)
  3. Parainfluenza-3 Virus (PI3)
  4. Bovine Viral Diarrhea Virus (BVD) BRD emphasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Infectious Bovine Rhinotraceitis IBR “Red Nose”

A

Virus characteristics
-Single serotype, 3 subtypes based on disease caused
-Other diseases: Reproductive Infectious pustular vulvaginitis (IPV), balanoposthitis, abortion. Conjunctivitis, encephalomyelitis, mastitis

Name
-Bovine Herpes Virus -1

Physical durability
Genetic features

Epidemiology:
-Transmission via oronasal secretions, spreads quickly. Peak shedding 3-6 days post exposure. Shedding stops 12-14 days

Distribution
Importance

Pathogenesis
-Onset after loss of maternal immunity usually >6mts of age
-Incubation period: 2-6 days
-Latent infection trigeminal ganglia in recovered cattle. Reactivation possible, immune suppression via leukocyte dysfunction and reduced numbers.

C/S

-Mild to severe disease, secondary bacterial pneumonia
-Fever >105F often
-Off-feed
-Cough
-Excessive salivation
-Inflammed nose “RED NOSE”
-Dyspnea if larynx is occluded with purulent material

Lesions
-Inflamed tissues with serous or serofibrinous exudate, blood tinged
-Larynx, trachea, sinuses
-Nasal cavity lesion externally seen
-Grayish, necrotic foci on membranes (pustules)
-Pseudodiphtheritic yellow plaques later on
-Erosions, ulcers, generalized infections in young animals

Dx

-C/S and lesions
-PCR from nasal secretions
-Serology antibodies
-Tissues from necropsy
-Secondary bacteria and viral co-infections

Tx

-Treat secondary bacterial pneumonia

Prevention and Control

-Vaccination: modified live vax
-Avoid in pregnant cattle
-Intranasal vax safe in pregnant animals
-Killed vax - whole virus
-Biosecurity
-Eradicated in Europe with DIVA vax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bovine Respiratory Synsytial Virus

A

Virus characteristics
-Cytopathic effect
-Only causes respiratory disease
-Possible antigenic subtypes
-Associated with BRD in young beef and dairy

Name
-Pneumovirus in Paramyxovirus RNA

Physical durability
Genetic features

Epidemiology
-Transmission: initial exposure by respiratory tract = severe disease, mild during subsequent exposures
-Distribution: worldwide indigenous in cattle populations: sheep goats can be affected
-Importance: high morbidity, 0-20% mortality

Pathogenesis
-LRT infection
-epithelial cells = destroys mucocilliary apparatus
-Alveolar macrophages
-Promotes secondary bacterial infections

C/S

-Fever 104-108F
-Lethargy
-Deceased feed intake
-Increased RR
-Cough
-Nasal and lacrimal discharge
-Dyspnea
-Open mouth breathing in later stages
-Subcutaneous
-Occasional biphasic disease pattern - mild then severe

Lesions

-Diffuse interstitial pneumonia
-Subpleural and interstitial edema
-Pulmonary emphysema “pulmonary bullae”
-Bronchopneumonia due to secondary bacteria is often present

Dx

-Histopath: multinucleate giant cells (syncytial) inclusion bodies, secondary bacteria = Fibrinous pneumonia
-Virus isolation
-PCR nasal swab
-Tissues IHC, FA
-Serology antibody

Tx

-Treat secondary bacterial infection
-Supportive therapy
-NSAIDs, fluids for dehydration
-Antihistamines
-Corticosteroids

Prevention and Control

-Vaccines killed and MLV
-Often combination IBR, BVD and PI3
-Also Mh and Pm IM and intranasal administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PI3

A

Virus characteristics
-RNA virus
-Grows in cell culture
-Hemagglutinates erythrocytes - serology
-Primary invader

Name
-Paramyxovirus

Physical durability
Genetic features

Epidemiology
-Transmission: by aerosol and direct contact
-Healthy calves often seroconvert
-Distribution: widespread in cattle
-Importance

Pathogenesis

-Only infects respiratory tract epithelial cells
-Nefcrosis of ciliated epithelial cells = impaired mucocilliary clearance
-Incubation 24-36 hours

C/S

-Fever
-Lethargy
-Off-fed
-Cough airway disease
-Increased respiratory rate
-Dyspnea
-Nasal and ocular discharge
-Altered lung sound
-Suggests pneumonia
-Cranioventral lung consolidation

Dx

-Histopath: bronchiolitis and alveolitis
-Intracytoplasmic inclusions: nasal epithelium
-Syncytia formation
-PCR nucleic acid
-Antigen detection
-Virus isolation
-IHC, FA
-Hemagglutination inhibition (HI)

Tx

-Address secondary bacterial infection
-Vaccination MLV, parenteral with IBR, BVD, BRSV, intranasal with IBR
-Killed vax
Prevention and Control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BVD

A

Virus characteristics
-Genus Pestivirus
-Type 1: sub genotypes a and b. Type Ib most common
-Type 2
-Similar to border disease virus and classical swine fever virus

Name
-Flaviviridae, Pestivirus

Physical durability

Genetic features
-ssRNA
-Enveloped
-Spherical capsid

Epidemiology

-Biotype Cytopathic and non-cytopathic
-Cytopathic rare
-Transmission: biting insects, fomites, semen, biologic products, wild animals??
-Distribution endemic worldwide, most important in some countries
-Importance

Pathogenesis

-3-24 months of age
-Causes immunosuppression = secondary bacterial pneumonia
-NCP: Persistently infected calf gestation day 30-110.
-Herd bull may become acutely infected if exposed to infected cows during breeding
-PI animals often die by 2 years of age
-PI cows always give birth to PI calves

C/S

-Reproductive dysfunction
-Respiratory complications
-Diarrhea
-Gastrointestinal ulcers/erosions
-Respiratory BRD
-Immune
-Integumentary
-Cardiovascular: hemorrhagic syndrome
-Reproductive: abortion anytime during gestation
-Biphasic fever
-Lethargy
-Inappetence
-Increased RR
-Excessive nasal secretions
-Diarrhea

Lesions

-Oral ulcers/erosion
-Coronary band eruptions
-Diarrhea
-Petechial hemorrhages in mucosal membranes
-Penumonia

Dx

-History and C/S
-Gross and microscopic lesions
-Necropsy: spleen, LNs, ulcerated GI tract segments
-PI calves: ear notch, fixed in formalin - IHC (single time point; high antigen amount compared to transient infection)
-VI buffy coat, PCR, antigen ELISA
-Repeat test >3 weeks to determine persistence
-Serology paired samples >4 fold increase in titer

Tx

-Secondary bacterial pneumonias and other infections
-Supportive

Prevention and Control

-Vaccination type I and type II combo
-Test for PI
-Biosecurity
-Quarantine for 2-4 weeks
-Herd control programs, screen milk/blood for PI cattle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Bovine Adenovirus

A

Virus characteristics
-Multiple serotypes 10
-Non-enveloped
-Resistant in environment

Name
Physical durability

Genetic features

Epidemiology

-Transmission
-Distribution
-Importance

Pathogenesis

-Widespread respiratory and GI infections
-Clinically inapparent

C/S
-No signs
-No known disease causation

Dx

-Culture
-PCR
-NGS

Prevention and Control

-No vax available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Bovine Coronavirus (BCV)

A

-RNA virus
-Enveloped unstable in environment
-Tropism for respiratory tract
-Single serotype

-Associated with neonatal calf diarrhea “winter dysentery”
-Co-infections common
-BRD clinical signs
-Difficult to isolate in culture
-Dx: PCR, standard methods
-Vax for enteric but not respiratory disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Bovine Rhinitis A and B

A

-Associated with BRD cases
-USA Rhinitis A virus 1
-Seropostive rates via IFA

20
Q

Bovine Influenza D and C virus (IDV)

A

-Orthomyxovirus
-RNA enveloped
-First detected in pigs
-Believed to play a role in BRD
Zoonotic complications
-Replicates in ferrets
-91% of cattle co-workers seropositive

21
Q

Bovine Respiratory Disease Complex

A

AKA: shipping fever, pneumonia, etc

-Most costly disease to the U.S cattle industry
-1 billion per year loses
Occurs around times of stress
-Weaning
-Commingling
-Shipping
-Weather
-Diet change
-Castration
-Dehorning
-Induction of abortion
-Branding

Disease progression

  1. Stress
  2. Viral component
  3. Bacterial component
  4. Lung tissue Damage: lung lesions

C/S

-Lethargic
-Depression
-Away from herd
-Fever
-Cough
-Nasal discharge
-Dyspneic
-Tachypneic
-Found dead!

Common life stages affected

Risk Factors

Occurs around times of stress
-Weaning
-Commingling
-Shipping
-Weather
-Diet change
-Castration
-Dehorning
-Induction of abortion
-Branding

22
Q

Major Bacterial Pathogens Associated with BRDC

Name and describe the major 4

A

Associated Conditions/diseases

  1. Manheimia hemolytica

-AKA: Pateurella haemolytica
-Most common bacterial pathogen
Causes the most lung damage
-Leukotoxin: causes death of neutrophils and release of enzymes, other inflammatory products
Fibrinopurulent bronchopneumonia
-Often cranioventral
-Can be sudden death
-Commensal bacteria in URT
-May carry antimicrobial resistant genes (MDR)
-Vaccines questionable efficacy

  1. Pasteurella multicocida

-Five serogroups
-Serogroup A in cattle
-Commonly in young calves
-Enzootic pneumonia in dairy calves
-Milder disease than Mh
-Less fibrin
-Part of normal flora in URT

  1. Hemophilus somni

-Other forms of disease: myocarditis, arthritis, TEME (thromboembolic meningeoncephalopathy)
-More common in certain geographic areas

  1. Mycoplasma bovis

-No cell wall, frustrating pathogen
-Beta lactase not effective
-Difficult to treat, especially after clinical signs have started
-Can be primary pathogen BRDC or secondary
-Found at necropsy after other pathogens are gone
Other manifestations: arthritis -lameness, otitis media - head tilt, mastitis

  1. Others:
    -Bibersteinia treholsi
    -Mycoplasma bovirhinis
    -Chlamydia psittaci
    -Salmonella
    -Trueperella pyogenes
    -Foreign animal disease: Mycoplasma mycoides contagious bovine pleuropneumonia
23
Q

BCDC Diagnosis

A

-Postmortem/necropsy
-Visual, temp, lung sounds, Ultrasound, TTW, NPS
-Bacterial culture/sensitivity
-PCR
-Confounding issues: calves may have been treated before you see them, only resistant bacteria left, secondary infection present

24
Q

Methods of measuring the severity of lung damage

A

Lung lesions

-Percentage of lobe damaged
-Consolidation, nonfunctional lung tissue
-Way to measure severity of disease
-Found at necropsy
-Determined at slaughter

25
Q

Important factors in mitigating BRDC, Prevention

A
  1. Vaccination

-Vaccination - viral pathogens
-Vaccination - bacterial pathogens
-Commercial and autogenous: M. haemolytica, P. multicocida, H. somni, M. bovis
-Autogenous: others

  1. Pre-condition

-Wean on farm
-Learn feed bunk
-Vaccinate properly: two doses prior to weaning

  1. Reduce Stress

-Bedding
-High fiber/roughage
-Water access
-Group with like cattle
-Shade
-Space
-Wind break

Tx

-Antimicrobials
-Metaphylaxis
-Mass treat
-Pull/treat
-NSAIDs: fever reduction
-Immune modulator
-Extra label treatments

26
Q

Lecture
Bovine Respiratory Disease Complex Treatment

A

BRD definition

-Temp 104F or >
-Shows C/S, lethargy, depression, nasal discharge, dyspnea, others.
-Usually scale 1-4
-Treatment, treatment failure, relapse

Morbidity
-How many of a group get sick, percentage

Mortality
-How many of a sick group died, percentage

Case fatality rate
-Of those treated, how many died
-Goal <10%
-Measure of treatment efficacy

Metaphylaxis
-Treatment administered on arrival at farm/stockyard, etc
-Control, not prevention

Treatment
-Usually up to three times
-Pull/chronic “railer” not recovered despite treatment

Mass treatment
-Entire group
-Percentage treated daily

High risk
-/+ 50% pull rate
-High mortality
-Young, light weight, unknown vax status, shipping, commingled.

Medium risk
-Preconditioned
-/+ vaccinated
-Morbidity 10-30%
-Mortality 1-5%

Low risk
-Morbidity <10%
-Mortality <1%

27
Q

Development of a treatment plan

A

Prior to arrival

-Determine risk classification: +/-metaphylaxis and antibiotic selection accordingly
-Identify sick animals: case definition, C/S, temp, etc.
-Accurate diagnosis

Chose Drug

+/- metaphylaxis and treatment (up to 3)
-Label indication
-Efficacy
-Cost
-Single, multiple dose
-Volume of dose
-Syringeability
-Route of admins
-Storage

Record Keeping

-Animal ID
-Withdrawal times
-Date of admins
-End of withdrawal
-Dose
-ROA
-Injection site

Treatment timing

-Metaphylaxis: not prevention
-After arrival: accurate diagnosis
-Antibiotics: usually up to 3 times, different antibiotics
-Chronic after 3 treatments

28
Q

Common Antibiotics Available

Class
Common route of administration
Duration of treatment
Withdrawal times and limitations for use based on age, production status and extra-label use regulations

A

Antimicrobial Drug Classes

  1. Macrolides
    Not for use in lactating dairy cattle

Tulathromycin (Draxxin)
Tilmicosin (Micotil)
Tildiporosin (Zuprevo)
Gamithomycin (Zactran)
Tylosin (Dylan) OTC

-MOA: inhibit protein synthesis at ribosome
-Typically bacteriostatic, can be bactericidal
-Newer molecules known for duration time above MIC
Spectrum: G (+), BRD (G-), anaerobes
-Distribution: weakly based, highly lipid soluble, poor CSF distribution

  1. Fenicols/Phenicols
    Not for use in lactating dairy cattle

Florfenicol (Nuflor, Nuflor Gold)
Resflor Gold (Florfenicol + Flunixin meglumine)

-MOA: Inhibit protein synthesis at 50s Subunit of ribosome
-Typically bacteriostatic, some bacterial isolates bactericidal
-Broadspectrum
-Rickettsial
-Distribution: lips soluble, including CSF

  1. Fluoroquinolones
    No extra label use

-Enrofloxacin (Baytril)
-Danofloxacin (Advocin)

-MOA: Inhibits DNA gyros and topoisomerase IV
-G (-), Rickettsia, Mycoplasma, Top 4 bacterial BRD pathogens, some G (+)
-Bactericidal
-Concentration dependent
-Good intracellular distribution
-Low plasma protein binding, CSF

  1. Beta Lactams
    Anaphylaxis
    PPG 30, 120 days withdrawal time

Penicillin (PPG, ampicillin)
Cephalosporins - Ceftiofur (Naxcel, Excel, Excede)
Ampicillin (Polyflex)
(more broad spectrum than penicillin)

-MOA: inhibit cell wall synthesis
-Narrow spectrum: G (+), anaerobes, fastidious G (-).
-Low volume distribution, no CSF, confined to plasma
-Ceftiofur: 3rd generation, fairly broad spectrum, less G (+). Time dependent, bactericidal.

  1. Tetracyclines

Oxytetracycline (LA 200, Bio-Mycin 200, Noromycin 300 LA)
Oxytetracycline + flunixin meglumine (Hexasol)

-MOA: Inhibits protein synthesis at 50s subunit of ribosome
-Bacteriostatic, bactericidal at high dose, concentration dependent
-Broadspectrum: G (+)? Rickettsial, Mycoplasma
-Distribution good except CSF
-Oral absorbed - calcium inhibits
-Slow IV, Nephrotoxic, irritating SQ IM

Oral Tetracyclines

-Water: No VFD, most common water med in pigs
-Feed: VFD required, variable dose in swine
-Labeled uses: scours, BRD, anaplasmosis

29
Q
A
30
Q
A
31
Q

Sulfonamides
Except Albon, Prohibited in lactating dairy cattle

A

Sulfadimethoxime (Albon and others)

-OTC
-Water, injectable
-No potentiated sulfonamides labeled, human drugs used in pigs

Sulfamethazine (Sustain III bolus & others)

-Scour, calf diphtheria
-OTC

AS700 oral pre-mix

-Sulfamethazine
-Chlortetracycline

32
Q

How to formulate antibiotic treatment protocols for BRD based on the animal, products available, administration and dosing constraints and economics

A

Withdrawal Times

0 days for milk: Cephalosporins Ceftiofur (Excede)
18 days for meat: Macrolides (Draxxin)
28 days BAL fluid: Tildipisorin (Zuprevo)
28 days for meat: Fenicols (Nuflor)
38 days for meat: Fenicols (Restflor Gold)
28 days for meat: Fluoroquinolones (Baytril)
13 days for meat: Beta lactams, Cephalosporins - Ceftiofur
28 days for meat: Tetracyclines

Duration of Therapy

-Macrolides (Draxxin) 10 days+
-Fenicols: short 48-72 hrs
-Fluoroquinolones: single dose
-Beta lactase, Cephalosporins Ceftiofur (Excede): 7 days
-Tetracyclines: 24-48 hours, 4 days max

33
Q

Describe how and why supportive therapeutic products such as NSAIDs are used of treating BRD

A

-Reduce stress
-NSAIDs: Benamine labeled for controlled of fever
-Corticosteroids
-Vitamins
-Antihistamines
-Immune stimulant/modulator: Zelnate, Plasmid DNA in liposome, stimulates innate immune system

34
Q

Describe the potential pitfalls encountered when formulating, implementing, and executing antibiotic treatment protocols

A

Read Product labels

-Indications
-Dosage
-ROA
-Withdrawal times
-Warnings
-More
**No extra label use for fluoroquinolone **
-Restricted use for cephalosporins

Treatment Failure

-Wrong diagnosis
-Viral BRDS
-Improper treatment dose
-Improper drug
-Antimicrobial resistance
-Relapse
-Treatment administered too late
-Lung damage/lesion too severe

35
Q

Lecture
BRD Vax, product approvals, adverse effects

A
36
Q

Available Respiratory Vaccines

A

Viral
-IBR: IN, MLV
-BVD Type 1&2: SQ, MLV
-BRSV: IN, MLV
-PI3: IN, MLV
-Corona? IN, MLV

Bacterial
-Pasteurella multicocida: IN, MLV
-Mannheimia Haemolytica: IN, MLV
-Histophilus somni: SQ, Killed

37
Q

Describe the window of susceptibility with regard to passive and active immunity

A

-Between birth and weaning
-When Maternal antibodies protection end and Active immunity is not fully stimulated
-Passive immunity decreases
-Active immunity begins to increase
The rate of maternal antibody decay rate is not constant across pathogens

Guiding principles

-FPT is not uncommon, navel ill, septic arthritis
-Maternal antibody titers (protection) wane over time
-Decay rate is pathogen specific
Maternal antibodies can interfere with active immunization
Vax goal is to stimulate active immunity before passive is gone

38
Q

Differences between killed and MLV, cost, reactivity, routes of administration

A

MLV

-Broader spectrum
-Less expensive to manufacture than killed
-More costly to develop
-Less reactive than killed if fully attenuated
-Can provide protection when given IN

Killed

-Less risk of contamination

39
Q

Immune stimulation Mechanism of mucosal immunization and overcoming maternal antibody interference

A

-Inherent responses compared to parenteral (SQ)
-Limited to MLV
-Depends on somewhat the level of “infection” induced by MLV
-Avoiding maternal antibody interference: because it is local, very low levels on mucosal surfaces, maternal AB are systemic

Overcoming Maternal Interference

-IN vaccines have shown to overcome maternal interference in: PI3, BHV-1, BRSV, BVDV, P. multicocida, IBR, BVD 1&2
-IN vaccines replicate in mucosa
-Prime mucosal immune system with little interference from maternal antibodies

40
Q

Mucosal Immune Response, M cell

A

-Mucosal-Associated Lymphoid Tissue
-Specialized epithelial (M-cells) sample the environment
-Oral cavity, small intestines, caecum, large intestine, rectum, respiratory tract.
-Take up antigen, transported and released at the basal surface, dendritic cells (activated T cells)
-Activated B cells provide humoral response. IgG, IgM, IgA produced
SQ administration does not induce local IgA, IgM

BVD SQ works <4 mts old
IBR, BRSV SQ <4 mts does not work

41
Q

Outcomes of excessive endotoxin levels in vaccines

A

-Derived from Gram (-) bacteria
-Capsular substance in the cell outer membrane
-Stimulate mediators of shock
-Inflammatory mediators released
-Decrease WBC count
-Increase temp
-Pulmonary edema
-Abortion and death
Avoid endotoxin “stacking”
-Simultaneous immunization of 2 or more vaccines

Mucosal surfaces and Endotoxins

-Adapted to manage and metabolize endotoxin
-Constantly exposed to gram (-)
-Very young animals better
-Reduce risk of disease

42
Q

Regulatory process for the approval of animal health products, agencies, pharmas and insecticides

A

Regulated by FDA so Phases are similar to Human Studies

-Preliminary studies
-Approval studies can be complicated: require field-based efficacy studies
-Pre-development
-Development: Minimum protective dose. Duration of immunity. Primary variables (disease), secondary variables (tissue levels and shedding). Field safety study required. Potency test validation for serial release.

  1. Target Animal Safety
  2. Effectiveness
  3. Human Food Safety
  4. Chemistry, Manufacturing, and Controls
  5. Environmental Impact
  6. All other information
  7. Labeling
  8. The Freedom of Information Summary
43
Q

Types of post-licensing studies

A
  1. Post market studies: usually directed by tech service; address customer questions
    -Example PCV2 vax
  2. Life cycle management: performed by R and D; label extensions (mostly indications)
44
Q

Role of practitioner in reporting adverse effects

A

Types of Adverse Effects

-SLEE: suspected lack of expected efficacy
-SAR: Suspected adverse reaction
-Also product defects

Who initiates - Everyone
-Attending vet
-Producer, customer, client, staff, others
-Found in public domain

Complaints to

-Regulatory agency
-Manufacturer
-Requirements to report: within firm, Pharma: report to FDA in X number of business days
-Bios: keep on file, may be reviewed during routine CVB inspection

45
Q

Regulatory agencies

A

FDA: Drugs
USDA: Vaccines
External chemicals: EPA